Učitavanje...
No free rides: management of toxicities of novel immunotherapies in ALL, including financial
Therapeutic options for acute lymphoblastic leukemia, especially in the relapsed/refractory setting, have expanded significantly in recent times. However, this comes at the cost of toxicities: medical as well as financial. We highlight some of the unique toxicities associated with the novel agents t...
Spremljeno u:
| Izdano u: | Blood Adv |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6258912/ https://ncbi.nlm.nih.gov/pubmed/30482769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018020198 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|